Merck Completes Enrolment of Evobrutinib Phase III Clinical Trials Ahead of ECTRIMS 2021

Press/Media

Period4 Oct 2021

Media coverage

1

Media coverage

  • TitleMerck Completes Enrolment of Evobrutinib Phase III Clinical Trials Ahead of ECTRIMS 2021
    Media name/outletMENAFN -Press Releases (English)
    Country/TerritoryJordan
    Date4/10/21
    PersonsDeirdre Bennett
View all 1
View less